对于未来的冠心病综合征患者，还能提供什么更多的治疗手段？
What More Can Be Delivered to Future Patients with Coronary Syndromes?
作者信息
Tanaka Atsushi, Node Koichi
机构信息
Department of Cardiovascular Medicine, Saga University, Saga 849-8501, Japan.
出版信息
J Clin Med. 2022 Sep 27;11(19):5704. doi: 10.3390/jcm11195704.
Abstract
Coronary artery disease (CAD) is a major cardiovascular disease that imposes substantial clinical and socioeconomic burdens worldwide [...].
摘要
冠状动脉疾病（CAD）是一种主要的心血管疾病，在全球范围内造成了巨大的临床和社会经济负担[……]。
相似文献
1
What More Can Be Delivered to Future Patients with Coronary Syndromes?对于未来的冠心病综合征患者，还能提供什么更多的治疗手段？
J Clin Med. 2022 Sep 27;11(19):5704. doi: 10.3390/jcm11195704.
2
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease.稳定型冠状动脉疾病门诊患者CLARIFY注册研究的原理、设计及基线特征
Clin Cardiol. 2017 Oct;40(10):797-806. doi: 10.1002/clc.22730. Epub 2017 May 31.
3
Socioeconomic Factors and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography: A Multicentre Study of Arabian Gulf States.接受冠状动脉造影术患者的社会经济因素与冠状动脉疾病严重程度：阿拉伯海湾国家的一项多中心研究
Open Cardiovasc Med J. 2017 Apr 28;11:47-57. doi: 10.2174/1874192401711010047. eCollection 2017.
4
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.稳定型冠状动脉疾病和急性冠状动脉综合征患者的髓过氧化物酶水平。
Eur J Clin Invest. 2008 Feb;38(2):90-6. doi: 10.1111/j.1365-2362.2007.01908.x.
5
One-Year Outcomes of Patients With Established Coronary Artery Disease Presenting With Acute Coronary Syndromes.患有稳定型冠状动脉疾病的急性冠状动脉综合征患者的一年预后。
Am J Cardiol. 2019 May 1;123(9):1387-1392. doi: 10.1016/j.amjcard.2019.01.037. Epub 2019 Feb 7.
6
Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: evidence-based analysis.用于无症状人群冠状动脉疾病筛查的多排螺旋计算机断层扫描：循证分析
Ont Health Technol Assess Ser. 2007;7(3):1-56. Epub 2007 May 1.
7
Echolucent carotid plaques predict future coronary events in patients with coronary artery disease.在冠心病患者中，颈动脉无回声斑块可预测未来的冠状动脉事件。
J Am Coll Cardiol. 2004 Apr 7;43(7):1177-84. doi: 10.1016/j.jacc.2003.09.063.
8
Genetic predisposition to type 2 diabetes is associated with severity of coronary artery disease in patients with acute coronary syndromes.2 型糖尿病的遗传易感性与急性冠脉综合征患者冠状动脉疾病严重程度相关。
Cardiovasc Diabetol. 2019 Oct 8;18(1):131. doi: 10.1186/s12933-019-0930-1.
9
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.替卡格雷与氯吡格雷在有症状外周动脉疾病和既往冠状动脉疾病患者中的比较：来自 EUCLID 试验的结果。
Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.
10
Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification.冠状动脉计算机断层扫描：心血管风险分层的当前作用和未来展望。
Eur Heart J Cardiovasc Imaging. 2012 Jun;13(6):453-8. doi: 10.1093/ehjci/jes081. Epub 2012 Apr 20.
本文引用的文献
1
Development of a Laboratory Risk-Score Model to Predict One-Year Mortality in Acute Myocardial Infarction Survivors.开发用于预测急性心肌梗死幸存者一年死亡率的实验室风险评分模型。
J Clin Med. 2022 Jun 17;11(12):3497. doi: 10.3390/jcm11123497.
2
Nitrates vs. Other Types of Vasodilators and Clinical Outcomes in Patients with Vasospastic Angina: A Propensity Score-Matched Analysis.硝酸盐类药物与其他类型血管扩张剂对变异性心绞痛患者临床结局的影响：一项倾向评分匹配分析
J Clin Med. 2022 Jun 7;11(12):3250. doi: 10.3390/jcm11123250.
3
A Japanese Dose of Prasugrel versus a Standard Dose of Clopidogrel in Patients with Acute Myocardial Infarction from the K-ACTIVE Registry.K-ACTIVE注册研究：日本剂量普拉格雷与标准剂量氯吡格雷治疗急性心肌梗死患者的比较
J Clin Med. 2022 Apr 4;11(7):2016. doi: 10.3390/jcm11072016.
4
A Novel Quantitative Parameter for Static Myocardial Computed Tomography: Myocardial Perfusion Ratio to the Aorta.一种用于静态心肌计算机断层扫描的新型定量参数：心肌灌注与主动脉比值。
J Clin Med. 2022 Mar 25;11(7):1816. doi: 10.3390/jcm11071816.
5
A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.一项前瞻性随机、双盲、多中心III期临床试验，评估奥美沙坦/氨氯地平联合瑞舒伐他汀治疗伴高血压和血脂异常患者的疗效和安全性：一项LEISURE研究。
J Clin Med. 2022 Jan 11;11(2):350. doi: 10.3390/jcm11020350.
6
Adjunctive Catheter-Directed Thrombolysis during Primary PCI for ST-Segment Elevation Myocardial Infarction with High Thrombus Burden.ST段抬高型心肌梗死伴高血栓负荷患者在直接经皮冠状动脉介入治疗期间的辅助导管定向溶栓治疗
J Clin Med. 2022 Jan 4;11(1):262. doi: 10.3390/jcm11010262.
7
Coronary Microvascular Vasodilatory Function: Related Clinical Features and Differences According to the Different Coronary Arteries and Types of Coronary Spasm.冠状动脉微血管舒张功能：相关临床特征及根据不同冠状动脉和冠状动脉痉挛类型的差异
J Clin Med. 2021 Dec 27;11(1):130. doi: 10.3390/jcm11010130.
8
Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm.血浆黄嘌呤氧化还原酶活性对冠状动脉痉挛影响的性别差异
J Clin Med. 2021 Nov 26;10(23):5550. doi: 10.3390/jcm10235550.
9
The Role of Uric Acid in Acute and Chronic Coronary Syndromes.尿酸在急性和慢性冠状动脉综合征中的作用。
J Clin Med. 2021 Oct 16;10(20):4750. doi: 10.3390/jcm10204750.
10
Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease.非ST段抬高型心肌梗死合并慢性肾脏病患者接受新一代药物洗脱支架植入术时多支血管病变不同再灌注策略的结果
J Clin Med. 2021 Oct 9;10(20):4629. doi: 10.3390/jcm10204629.
Zotero 插件